Targeting LRRK2 in Parkinson's disease: an update on recent developments
10.1080/14728222.2017.1323881
Saved in:
Main Authors: | Chan S.L., Tan E.-K. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
Taylor and Francis Ltd
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/148995 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pathogenicity of LRRK2 P755L variant in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018) -
Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease
by: Bialecka M., et al.
Published: (2018) -
LRRK2 mutations are not frequent in Swiss patients with Parkinson's disease
by: Burgunder, J.-M., et al.
Published: (2011) -
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
by: Tan E.K., et al.
Published: (2018) -
Genetic testing of LRRK2 in Parkinson's disease: Is there a clinical role?
by: Buhat D.M.L., et al.
Published: (2018)